Pfizer, Inc.
PFE
$ 51.59
2.99%
Marketcap
289.47B
Volume
$ 22,910,509.00
Shares
5,610,899,968
Range
$ 50.30 – $ 51.64
52 Week Range
$ 38.82 – $ 61.71

More Info for Pfizer, Inc. (PFE)

  • Charts
  • Brokers

  • Description

  • News

  • Comments

Stocks Brokers
Get:
Social
Trading Platform
Follow and Copy the Best Trader on the Largest Social Trading Platform.
4.3 rating
4.3
‏Disclaimer
New customers only

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when trading CFDs with this provider.

Join more than
1 million
clients that place their trust
One of 160 largest listed companies in Germany.
3.0 rating
3.0
Disclaimer
New customers only

Investing can be rewarding but it is not without risk. You can lose your deposit. At DEGIRO, we are open and transparent about the risks that come with investing. Before you start to invest, there are a number of factors to consider. You can read more about the risks of investing in our Investors Services Information documents or our dedicated risk page.

Get up to:
50% lower than the industry
Earn extra income on your lendable shares
Free Trading Tools
2.0 rating
2.0
Disclaimer
New customers only

Warning: Your capital is at risk and your losses may exceed the value of your original investment.

Is authorised and regulated by the Financial Conduct Authority. FCA register entry number 208159.
Pfizer, Inc.
Symbol: PFE
Employees: 79000
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women’s health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
NYQ
Healthcare
Drug Manufacturers—General
235 East 42nd Street, New York, NY, United States
United States

How to invest on Pfizer, Inc.?

To invest or trade stocks Pfizer, Inc. you need a broker to execute your positions.
But before directing you to a broker compatible with your needs, I would like to give you a Stock Summary on Pfizer, Inc..

Pfizer, Inc.(PFE) stock market review

The company Pfizer, Inc. based in United States, is specialized in the Drug Manufacturers—General industry, the Healthcare sector and employs more than 79,000 employees.

The Pfizer, Inc. (PFE) share price is currently $ 51.59 with 5,610,899,968 shares outstanding, representing a market cap of $ 289,466,318,848.00. The daily volume is 22,910,509 and the previous close of the share value was $ 50.09.
Over the past 52 weeks, the stock has traded low at $ 38.82 and high at $ 61.71.
Pfizer, Inc. offers earnings per share of 4.44.
Regarding dividends, the dividend yield for Pfizer, Inc. is 3.1343583 and the dividend rate is 1.57.

Choose a Broker to trade on Pfizer, Inc.

There are several things to check before taking your first steps with your new broker. This is the reason why at AdonFinance we find the broker that suits you. To view the article on how to choose a broker, go to the site menu, and click on Brokers.

To choose a broker who offers the possibility of trading on the Pfizer, Inc. (PFE ) share, click on the button below:

Find Brokers for Pfizer, Inc. (PFE)

Get:
Social
Trading Platform
Follow and Copy the Best Trader on the Largest Social Trading Platform.
4.3 rating
4.3
‏Disclaimer
New customers only

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when trading CFDs with this provider.

Join more than
1 million
clients that place their trust
One of 160 largest listed companies in Germany.
3.0 rating
3.0
Disclaimer
New customers only

Investing can be rewarding but it is not without risk. You can lose your deposit. At DEGIRO, we are open and transparent about the risks that come with investing. Before you start to invest, there are a number of factors to consider. You can read more about the risks of investing in our Investors Services Information documents or our dedicated risk page.

Get up to:
50% lower than the industry
Earn extra income on your lendable shares
Free Trading Tools
2.0 rating
2.0
Disclaimer
New customers only

Warning: Your capital is at risk and your losses may exceed the value of your original investment.

Is authorised and regulated by the Financial Conduct Authority. FCA register entry number 208159.

Leave a Reply

Your email address will not be published.

AdonFinance
Risk Warning: The material on this website is provided for informational purposes only and does not constitute an offer to sell, a solicitation to buy, or a recommendation or endorsement for any security or strategy, nor does it constitute an offer to provide investment advisory or other services by AdonFinance. In addition, the content of the website offers no opinion with respect to the suitability of any security or any specific investment. Trading foreign exchange, stocks, cryptocurrencies and commodities is potentially high risk and may not be suitable for all investors. The high level of leverage can work both for and against traders. Before any investment with any broker you need to carefully consider your targets, previous experience, and risk level. Forex trading can result in the loss of your money, as a result, you are expressly cautioned that you should never invest or trade with money that you cannot afford to lose. For the avoidance of doubt, AdonFinance's service provides Brokers reviews in the Financial market. AdonFinance, its subsidiaries, agents or affiliates will assume no responsibility whatsoever for your trading activity. © Copyright 2021 AdonFinance